Flat Medical has announced the acquisition of InjeQ’s assets, including the IQ-Tip needle system, which received the US Food and Drug Administration (FDA) breakthrough device designation.

The financial specifics of the transaction remain undisclosed.

This acquisition enhances Flat Medical’s portfolio with advanced healthcare solutions.

The deal encompasses InjeQ’s technology assets and intellectual property, as well as the IQ-Tip system, which employs bioimpedance-based tissue recognition technology to enable precise tissue type differentiation and improve the safety of several medical procedures.

Flat Medical CTO Liyu Lin said: “We are thrilled to welcome InjeQ’s groundbreaking technology into the Flat Medical family.

“The IQ-Tip represents a significant advancement in tissue recognition technology, and we’re excited to leverage our resources and expertise to bring this innovative solution to healthcare providers and patients worldwide.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Flat Medical aims to expedite the development and market introduction of the IQ-Tip, ensuring rapid accessibility for healthcare providers and patients.

The company is dedicated to the ongoing enhancement of the technology, with potential applications in a range of medical areas beyond its current usage.

Lin added: “This versatile technology has the capacity to revolutionise a wide range of clinical interventions that require accurate tissue identification.

“We envision its application in various fields of medicine, enhancing precision and patient safety across multiple procedures.”

Based in Taipei City, Taiwan, Flat Medical is engaged in the development of safety and precision solutions for pain management, anaesthesia, and intensive and critical care.

The company’s product portfolio includes products such as EpiFaith and EpiFaith CV, which enable medical professionals to ensure successful and secure procedures.